Robert Charles Stone, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 405 S Cavin St, Ligonier, IN 46767 Phone: 260-894-4187 Fax: 260-894-4188 |
News Archive
Use of the botanical product silymarin, an extract of milk thistle that is commonly used by some patients with chronic liver disease, did not provide greater benefit than placebo for patients with treatment-resistant chronic hepatitis C virus (HCV) infection, according to a study in the July 18 issue of JAMA.
A recent study by a Saint Louis University researcher confirms findings that about half of the U.S. population has a version of a gene that causes them to metabolize food differently, putting them at greater risk of developing diabetes.
Bile duct cancer is rare and is usually detected too late. Often only extensive liver surgery can help or, in rare cases, liver transplantation. But which patients will benefit from surgery and which will not, because their risk of cancer recurrence is too high? With the oncogene MACC1 as a biomarker, physicians for the first time have a tool to decide which treatment option is best for patients with Klatskin carcinoma, one type of bile duct cancer.
Medical research charity Arthritis Research UK has awarded £250,000 to a team of researchers at the University of Bristol and the University of Aberdeen to study which genes can lead to people developing painful and common osteoarthritis of the hip.
› Verified 3 days ago